Find and Pitch Jounalists, Get Your Story Covered

Tags: Caris Life Sciences Moderna oncology art tv

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Scottish medicines consortium approves CAR T-cell therapy for blood cancer - 4 days ago
2	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 10 days ago STAT+: Gilead needs a win with Arcellx CAR-T data. Here’s how to know if it scores - 22 days ago STAT+: Allogene to pursue new strategy for development of off-the-shelf cell therapy in blood cancer - 11 months ago STAT+: Bristol Myers to purchase Karuna, maker of schizophrenia drug, for $14 billion - 11 months ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	California is a life sciences leader. Joe Panetta has been one of its most vocal advocates. - about 1 month ago Mining clues from a library of brain tissue samples, Cerevance takes a precision approach to CNS disorders - 4 months ago As BMS announces major cuts, its Karuna deal looks poised to drive growth - 7 months ago Astellas’ science chief on the leap into new technologies - 9 months ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Lilly lays down $1B to be ‘first in biology’ with obesity gene therapies - 2 months ago Kyverna follows oncology’s CAR-T cell playbook for an ultra-rare autoimmune disorder - 4 months ago Is a better CAR-T cell therapy option on the horizon? - 4 months ago Ahead of its upcoming decision date, a competitor takes aim at KarXT - 5 months ago 4 offbeat biotechs making a splash in the life sciences - 7 months ago
5	Danielle Gerhard, PhD The Scientist Assistant Editor @TheScientistLLC. United Kingdom scienceediting	From Lab Coat to Legislation - 2 months ago Infographic: Understanding CAR-T vs TCR Approaches - 8 months ago Next-generation CAR and TCR Cancer Therapies - 8 months ago
6	Ricky Zipp MedTech Dive Health Analyst, science master. Brooklyn, New York health analysisscience	Cepheid to cut more than 600 employees in California - 3 months ago
7	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Biotech led by J&J veterans launches with $165 million for cancer, autoimmune therapies - 4 months ago STAT+: Biotech incubator Curie.Bio graduates its first startup - about 1 year ago STAT+: Life science investors close nearly $6 billion in new funds - about 1 year ago
8	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Element Biosciences raises another massive round - 4 months ago Novartis reportedly decides to pass on Cytokinetics - 10 months ago Novartis is building a new radioligand plant in China - 12 months ago
9	Sean O'Kane TechCrunch Studio Manager. London, England studio managementretail design	Volkswagen’s Silicon Valley software hub is already stacked with Rivian talent - 5 months ago
10	Kirsten Korosec TechCrunch Transportation editor at TechCrunch. Co-host of The Autonocast. transportationfuture of transportationhelmetsbackcountry	Volkswagen’s Silicon Valley software hub is already stacked with Rivian talent - 5 months ago

Journalists covering Caris Life Sciences